Inhaled pirfenidone solution (AP01) for IPF: a randomised, open-label, dose-response trial.

Saved in:
Bibliographic Details
Title: Inhaled pirfenidone solution (AP01) for IPF: a randomised, open-label, dose-response trial.
Authors: West A; Guy's and St Thomas' Hospital, London, UK., Chaudhuri N; University of Ulster, Magee Campus, Londonderry, UK., Barczyk A; Department of Pneumonology, Medical University of Silesia, Katowice, Slaskie, Poland., Wilsher ML; Respiratory Services, Auckland District Health Board, Auckland, New Zealand., Hopkins P; The Prince Charles Hospital, Brisbane, Queensland, Australia., Glaspole I; Department of Respiratory Medicine, Alfred Hospital, Melbourne, Victoria, Australia., Corte TJ; Department of Respiratory Medicine, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.; Department of Respiratory Medicine, Royal Brompton Hospital, London, UK., Šterclová M; Department of Respiratory Medicine, Thomayer Hospital, Praha, Praha, Czech Republic., Veale A; Department of Respiratory Medicine, Queen Elizabeth Hospital, Woodville South, South Australia, Australia., Jassem E; Gdanski Uniwersytet Medyczny, Gdansk, Poland., Wijsenbeek MS; Department of Respiratory Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands., Grainge C; Hunter Medical Research Institute, University of Newcastle, New Castle, New South Wales, Australia., Piotrowski W; Department of Pneumonology and Allergy, Medical University of Lodz, Lodz, Lodzkie, Poland., Raghu G; CENTER for Interstitial Lung Diseases, University of Washington, Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA., Shaffer ML; Avalyn Pharma Inc, Seattle, Washington, USA., Nair D; Avalyn Pharma Inc, Seattle, Washington, USA., Freeman L; Avalyn Pharma Inc, Seattle, Washington, USA., Otto K; Avalyn Pharma Inc, Seattle, Washington, USA., Montgomery AB; Avalyn Pharma Inc, Seattle, Washington, USA bruce.montgomerymd@gmail.com.
Source: Thorax [Thorax] 2023 Sep; Vol. 78 (9), pp. 882-889. Date of Electronic Publication: 2023 Mar 22.
Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: British Medical Assn Country of Publication: England NLM ID: 0417353 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-3296 (Electronic) Linking ISSN: 00406376 NLM ISO Abbreviation: Thorax Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1468-3296
DOI:10.1136/thorax-2022-219391